Hosted on MSN1h
3 Reasons HSIC is Risky and 1 Stock to Buy InsteadHenry Schein has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The ...
former CEO of Henry Schein's Global Dental Group, and A.J. Caffentzis, former president of its U.S. dental division. The departures raised concerns that top executives who might have been ...
Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor disclosed a strategic investment of an additional $250 million from funds ...
BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the distributor of medical products said on Wednesday. Shares of Henry Schein ...
State of Alaska Department of Revenue lowered its holdings in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 37.5% in the 4th quarter, according to the company in its most recent 13F filing with ...
KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s largest distributor of medical products to office-based dentists and doctors.
Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is paying tribute to women athletic ...
Henry Schein said it expects to report earnings and revenue growth in the fourth quarter and forecast further gains in 2025 adjusted earnings, even as it confirmed an activist-investment deal with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results